228 related articles for article (PubMed ID: 31058608)
1. Five miRNAs-mediated PIEZO2 downregulation, accompanied with activation of Hedgehog signaling pathway, predicts poor prognosis of breast cancer.
Lou W; Liu J; Ding B; Jin L; Xu L; Li X; Chen J; Fan W
Aging (Albany NY); 2019 May; 11(9):2628-2652. PubMed ID: 31058608
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of the miR-17-92 cluster and miR-17 family in breast cancer according to tumor type; results from the Norwegian Women and Cancer (NOWAC) study.
Moi L; Braaten T; Al-Shibli K; Lund E; Busund LR
J Transl Med; 2019 Oct; 17(1):334. PubMed ID: 31581940
[TBL] [Abstract][Full Text] [Related]
3. Deregulated microRNAs in triple-negative breast cancer revealed by deep sequencing.
Chang YY; Kuo WH; Hung JH; Lee CY; Lee YH; Chang YC; Lin WC; Shen CY; Huang CS; Hsieh FJ; Lai LC; Tsai MH; Chang KJ; Chuang EY
Mol Cancer; 2015 Feb; 14():36. PubMed ID: 25888956
[TBL] [Abstract][Full Text] [Related]
4. NCAPG upregulation mediated by four microRNAs combined with activation of the p53 signaling pathway is a predictor of poor prognosis in patients with breast cancer.
Dong M; Xu T; Cui X; Li H; Li X; Xia W
Oncol Lett; 2021 Apr; 21(4):323. PubMed ID: 33692855
[TBL] [Abstract][Full Text] [Related]
5. High-throughput screens identify microRNAs essential for HER2 positive breast cancer cell growth.
Leivonen SK; Sahlberg KK; Mäkelä R; Due EU; Kallioniemi O; Børresen-Dale AL; Perälä M
Mol Oncol; 2014 Feb; 8(1):93-104. PubMed ID: 24148764
[TBL] [Abstract][Full Text] [Related]
6. Meta-microRNA Biomarker Signatures to Classify Breast Cancer Subtypes.
Oztemur Islakoglu Y; Noyan S; Aydos A; Gur Dedeoglu B
OMICS; 2018 Nov; 22(11):709-716. PubMed ID: 30388053
[TBL] [Abstract][Full Text] [Related]
7. The lncRNA GATA3-AS1/miR-495-3p/CENPU axis predicts poor prognosis of breast cancer via the PLK1 signaling pathway.
Lin S; Zhao M; Lv Y; Mao G; Ding S; Peng F
Aging (Albany NY); 2021 Apr; 13(10):13663-13679. PubMed ID: 33902008
[TBL] [Abstract][Full Text] [Related]
8. Crosstalk between the vitamin D receptor (VDR) and miR-214 in regulating SuFu, a hedgehog pathway inhibitor in breast cancer cells.
Alimirah F; Peng X; Gupta A; Yuan L; Welsh J; Cleary M; Mehta RG
Exp Cell Res; 2016 Nov; 349(1):15-22. PubMed ID: 27693451
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer.
Vilquin P; Donini CF; Villedieu M; Grisard E; Corbo L; Bachelot T; Vendrell JA; Cohen PA
Breast Cancer Res; 2015 Jan; 17(1):13. PubMed ID: 25633049
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-β1 promotes breast cancer metastasis by downregulating miR-196a-3p expression.
Chen Y; Huang S; Wu B; Fang J; Zhu M; Sun L; Zhang L; Zhang Y; Sun M; Guo L; Wang S
Oncotarget; 2017 Jul; 8(30):49110-49122. PubMed ID: 28418877
[TBL] [Abstract][Full Text] [Related]
11. miR-142-3p as tumor suppressor miRNA in the regulation of tumorigenicity, invasion and migration of human breast cancer by targeting Bach-1 expression.
Mansoori B; Mohammadi A; Ghasabi M; Shirjang S; Dehghan R; Montazeri V; Holmskov U; Kazemi T; Duijf P; Gjerstorff M; Baradaran B
J Cell Physiol; 2019 Jun; 234(6):9816-9825. PubMed ID: 30480817
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA regulation of progesterone receptor in breast cancer.
Gilam A; Shai A; Ashkenazi I; Sarid LA; Drobot A; Bickel A; Shomron N
Oncotarget; 2017 Apr; 8(16):25963-25976. PubMed ID: 28404930
[TBL] [Abstract][Full Text] [Related]
13. Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling.
Zhang K; Wang YW; Wang YY; Song Y; Zhu J; Si PC; Ma R
Gene; 2017 Jul; 619():10-20. PubMed ID: 28359916
[TBL] [Abstract][Full Text] [Related]
14. miRNA expression in breast cancer varies with lymph node metastasis and other clinicopathologic features.
Wang B; Li J; Sun M; Sun L; Zhang X
IUBMB Life; 2014 May; 66(5):371-7. PubMed ID: 24846313
[TBL] [Abstract][Full Text] [Related]
15. Cell division cycle proteinising prognostic biomarker of breast cancer.
Cheng L; Huang YZ; Chen WX; Shi L; Li Z; Zhang X; Dai XY; Wei JF; Ding Q
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32285914
[TBL] [Abstract][Full Text] [Related]
16. High Expression of Pseudogene PTTG3P Indicates a Poor Prognosis in Human Breast Cancer.
Lou W; Ding B; Fan W
Mol Ther Oncolytics; 2019 Sep; 14():15-26. PubMed ID: 31011629
[TBL] [Abstract][Full Text] [Related]
17. Downregulated miR-1247-5p associates with poor prognosis and facilitates tumor cell growth via DVL1/Wnt/β-catenin signaling in breast cancer.
Zeng B; Li Y; Feng Y; Lu M; Yuan H; Yi Z; Wu Y; Xiang T; Li H; Ren G
Biochem Biophys Res Commun; 2018 Oct; 505(1):302-308. PubMed ID: 30249392
[TBL] [Abstract][Full Text] [Related]
18. Clinical Value of miR-101-3p and Biological Analysis of its Prospective Targets in Breast Cancer: A Study Based on The Cancer Genome Atlas (TCGA) and Bioinformatics.
Li CY; Xiong DD; Huang CQ; He RQ; Liang HW; Pan DH; Wang HL; Wang YW; Zhu HW; Chen G
Med Sci Monit; 2017 Apr; 23():1857-1871. PubMed ID: 28416776
[TBL] [Abstract][Full Text] [Related]
19. CLIP4 Shows Putative Tumor Suppressor Characteristics in Breast Cancer: An Integrated Analysis.
Fan Y; He L; Wang Y; Fu S; Han Y; Fan J; Wen Q
Front Mol Biosci; 2020; 7():616190. PubMed ID: 33575272
[No Abstract] [Full Text] [Related]
20. Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation.
Lou W; Chen J; Ding B; Chen D; Zheng H; Jiang D; Xu L; Bao C; Cao G; Fan W
J Transl Med; 2018 Sep; 16(1):266. PubMed ID: 30268144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
